A validation study of the Siriraj Stroke Score.

Area of Science:

• Neurology
• Clinical Medicine

Background:

• Acute stroke diagnosis relies on differentiating between ischemic and hemorrhagic events.
• Accurate stroke classification is crucial for appropriate treatment selection, including thrombolytic and anticoagulant therapies.
• The Siriraj Stroke Score (SSS) has been proposed as a clinical tool for rapid stroke type differentiation.

Purpose of the Study:

• To validate the clinical usefulness of the Siriraj Stroke Score (SSS) in a Malaysian population.
• To assess the SSS's accuracy in differentiating between intracerebral hemorrhage and infarction in acute stroke patients.
• To determine the SSS's suitability for epidemiological studies and clinical decision-making in acute stroke management.

Main Methods:

• A cross-sectional study involving 160 Malaysian patients with acute stroke.
• Validation of the Siriraj Stroke Score (SSS) against confirmed stroke diagnoses.
• Analysis of the SSS's sensitivity and specificity for identifying stroke subtypes.

Main Results:

• The Siriraj Stroke Score (SSS) demonstrated low sensitivity and specificity in differentiating intracerebral hemorrhage from infarction.
• The study found the SSS to be inadequate for reliable stroke type determination in the studied population.
• Results indicate significant limitations in using the SSS for epidemiological assessments of stroke subtypes.

Conclusions:

• The Siriraj Stroke Score (SSS) is not recommended for epidemiological studies to determine stroke types in the community.
• Physicians should not rely solely on the SSS for assessing the need for thrombolytic or anticoagulant therapy in acute stroke patients, especially without neuroimaging.
• Clinical decision-making for acute stroke management requires more definitive diagnostic methods than the SSS.